Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Soft Tissue Acellular Dermal Matrix (ADM) Market Insights, Forecast to 2030
Global Soft Tissue Acellular Dermal Matrix (ADM) Market Insights, Forecast to 2030
Industry: Medical Devices & Consumables
Published Date: 2024-11-15
Pages: 150 Pages
Report ld: 3379501
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Soft Tissue Acellular Dermal Matrix (ADM) Market Size(US$)
CAGR 2024-2030
2.8%
Market Size,2030
USD 105
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 89.2 million
Market Forecast in 2030(Value)
US$ 105 million
CAGR
2.8%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Soft Tissue Acellular Dermal Matrix (ADM) market is projected to grow from US$ 89.2 million in 2024 to US$ 105 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.8% during the forecast period.
Soft Tissue Acellular Dermal Matrix (ADM) is a specialized graft material used in various surgical and reconstructive procedures. It is created from donor tissue, usually from human or animal sources, that has been processed to remove all cells, leaving behind a collagen-rich matrix. This acellular matrix acts as a scaffold that supports cell attachment and tissue regeneration, integrating with the patient's own tissue over time.
The US & Canada market for Soft Tissue Acellular Dermal Matrix (ADM) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Soft Tissue Acellular Dermal Matrix (ADM) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Soft Tissue Acellular Dermal Matrix (ADM) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Soft Tissue Acellular Dermal Matrix (ADM) include Zimmer Biomet, Allergan, Stryker, MTF Biologics, LifeNet Health, Integra LifeSciences, Medtronic, Arthrex, Straumann, Wright Medical Group, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Soft Tissue Acellular Dermal Matrix (ADM), sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Soft Tissue Acellular Dermal Matrix (ADM), also provides the sales of main regions and countries. Highlights of the upcoming market potential for Soft Tissue Acellular Dermal Matrix (ADM), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Soft Tissue Acellular Dermal Matrix (ADM) sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Soft Tissue Acellular Dermal Matrix (ADM) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Soft Tissue Acellular Dermal Matrix (ADM) sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Zimmer Biomet, Allergan, Stryker, MTF Biologics, LifeNet Health, Integra LifeSciences, Medtronic, Arthrex, Straumann, Wright Medical Group, etc.
MARKET SEGMENTATION
By Company
- Zimmer Biomet
- Allergan
- Stryker
- MTF Biologics
- LifeNet Health
- Integra LifeSciences
- Medtronic
- Arthrex
- Straumann
- Wright Medical Group
- Hans Biomed
- Xtant Medical
- Yantai Zhenghai Bio-Tech
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Human Skin
- Animal Skin
Segment by Application
- Plastic Surgery
- Gynecology
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Soft Tissue Acellular Dermal Matrix (ADM) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Soft Tissue Acellular Dermal Matrix (ADM) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Soft Tissue Acellular Dermal Matrix (ADM) sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Soft Tissue Acellular Dermal Matrix (ADM) Product Introduction
1.2 Market by Type
1.2.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Human Skin
1.2.3 Animal Skin
1.3 Market by Application
1.3.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Plastic Surgery
1.3.3 Gynecology
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Estimates and Forecasts 2019-2030
2.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Region
2.2.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Region (2019-2024)
2.2.3 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Region (2025-2030)
2.2.4 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Region (2019-2030)
2.3 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Estimates and Forecasts 2019-2030
2.4 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Region
2.4.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Region (2019-2024)
2.4.3 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Region (2025-2030)
2.4.4 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Manufacturers
3.1.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Manufacturers (2019-2024)
3.1.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Soft Tissue Acellular Dermal Matrix (ADM) in 2023
3.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Manufacturers
3.2.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Manufacturers (2019-2024)
3.2.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Soft Tissue Acellular Dermal Matrix (ADM) Revenue in 2023
3.3 Global Key Players of Soft Tissue Acellular Dermal Matrix (ADM), Industry Ranking, 2021 VS 2022
3.4 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Price by Manufacturers (2019-2024)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Soft Tissue Acellular Dermal Matrix (ADM), Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Soft Tissue Acellular Dermal Matrix (ADM), Product Offered and Application
3.8 Global Key Manufacturers of Soft Tissue Acellular Dermal Matrix (ADM), Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Type
4.1.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Historical Sales by Type (2019-2024)
4.1.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Forecasted Sales by Type (2025-2030)
4.1.3 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Type (2019-2030)
4.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Type
4.2.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Historical Revenue by Type (2019-2024)
4.2.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Forecasted Revenue by Type (2025-2030)
4.2.3 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Type (2019-2030)
4.3 Global Soft Tissue Acellular Dermal Matrix (ADM) Price by Type
4.3.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Price by Type (2019-2024)
4.3.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Application
5.1.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Historical Sales by Application (2019-2024)
5.1.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Forecasted Sales by Application (2025-2030)
5.1.3 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Application (2019-2030)
5.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Application
5.2.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Historical Revenue by Application (2019-2024)
5.2.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Forecasted Revenue by Application (2025-2030)
5.2.3 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Application (2019-2030)
5.3 Global Soft Tissue Acellular Dermal Matrix (ADM) Price by Application
5.3.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Price by Application (2019-2024)
5.3.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Market Size by Type
6.1.1 US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Sales by Type (2019-2030)
6.1.2 US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Type (2019-2030)
6.2 US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Market Size by Application
6.2.1 US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Sales by Application (2019-2030)
6.2.2 US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Application (2019-2030)
6.3 US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Market Size by Country
6.3.1 US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country (2019-2030)
6.3.3 US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Sales by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Soft Tissue Acellular Dermal Matrix (ADM) Market Size by Type
7.1.1 Europe Soft Tissue Acellular Dermal Matrix (ADM) Sales by Type (2019-2030)
7.1.2 Europe Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Type (2019-2030)
7.2 Europe Soft Tissue Acellular Dermal Matrix (ADM) Market Size by Application
7.2.1 Europe Soft Tissue Acellular Dermal Matrix (ADM) Sales by Application (2019-2030)
7.2.2 Europe Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Application (2019-2030)
7.3 Europe Soft Tissue Acellular Dermal Matrix (ADM) Market Size by Country
7.3.1 Europe Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country (2019-2030)
7.3.3 Europe Soft Tissue Acellular Dermal Matrix (ADM) Sales by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Soft Tissue Acellular Dermal Matrix (ADM) Market Size by Type
8.1.1 China Soft Tissue Acellular Dermal Matrix (ADM) Sales by Type (2019-2030)
8.1.2 China Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Type (2019-2030)
8.2 China Soft Tissue Acellular Dermal Matrix (ADM) Market Size by Application
8.2.1 China Soft Tissue Acellular Dermal Matrix (ADM) Sales by Application (2019-2030)
8.2.2 China Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Soft Tissue Acellular Dermal Matrix (ADM) Market Size by Type
9.1.1 Asia Soft Tissue Acellular Dermal Matrix (ADM) Sales by Type (2019-2030)
9.1.2 Asia Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Type (2019-2030)
9.2 Asia Soft Tissue Acellular Dermal Matrix (ADM) Market Size by Application
9.2.1 Asia Soft Tissue Acellular Dermal Matrix (ADM) Sales by Application (2019-2030)
9.2.2 Asia Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Application (2019-2030)
9.3 Asia Soft Tissue Acellular Dermal Matrix (ADM) Market Size by Region
9.3.1 Asia Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Region (2019-2030)
9.3.3 Asia Soft Tissue Acellular Dermal Matrix (ADM) Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
9.3.9 Australia
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Market Size by Type
10.1.1 Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Market Size by Application
10.2.1 Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Market Size by Country
10.3.1 Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Corporate Profile
11.1 Zimmer Biomet
11.1.1 Zimmer Biomet Company Information
11.1.2 Zimmer Biomet Overview
11.1.3 Zimmer Biomet Soft Tissue Acellular Dermal Matrix (ADM) Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Zimmer Biomet Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Zimmer Biomet Recent Developments
11.2 Allergan
11.2.1 Allergan Company Information
11.2.2 Allergan Overview
11.2.3 Allergan Soft Tissue Acellular Dermal Matrix (ADM) Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Allergan Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Allergan Recent Developments
11.3 Stryker
11.3.1 Stryker Company Information
11.3.2 Stryker Overview
11.3.3 Stryker Soft Tissue Acellular Dermal Matrix (ADM) Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Stryker Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Stryker Recent Developments
11.4 MTF Biologics
11.4.1 MTF Biologics Company Information
11.4.2 MTF Biologics Overview
11.4.3 MTF Biologics Soft Tissue Acellular Dermal Matrix (ADM) Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 MTF Biologics Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 MTF Biologics Recent Developments
11.5 LifeNet Health
11.5.1 LifeNet Health Company Information
11.5.2 LifeNet Health Overview
11.5.3 LifeNet Health Soft Tissue Acellular Dermal Matrix (ADM) Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 LifeNet Health Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 LifeNet Health Recent Developments
11.6 Integra LifeSciences
11.6.1 Integra LifeSciences Company Information
11.6.2 Integra LifeSciences Overview
11.6.3 Integra LifeSciences Soft Tissue Acellular Dermal Matrix (ADM) Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Integra LifeSciences Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Integra LifeSciences Recent Developments
11.7 Medtronic
11.7.1 Medtronic Company Information
11.7.2 Medtronic Overview
11.7.3 Medtronic Soft Tissue Acellular Dermal Matrix (ADM) Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Medtronic Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Medtronic Recent Developments
11.8 Arthrex
11.8.1 Arthrex Company Information
11.8.2 Arthrex Overview
11.8.3 Arthrex Soft Tissue Acellular Dermal Matrix (ADM) Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Arthrex Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Arthrex Recent Developments
11.9 Straumann
11.9.1 Straumann Company Information
11.9.2 Straumann Overview
11.9.3 Straumann Soft Tissue Acellular Dermal Matrix (ADM) Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Straumann Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Straumann Recent Developments
11.10 Wright Medical Group
11.10.1 Wright Medical Group Company Information
11.10.2 Wright Medical Group Overview
11.10.3 Wright Medical Group Soft Tissue Acellular Dermal Matrix (ADM) Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Wright Medical Group Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Wright Medical Group Recent Developments
11.11 Hans Biomed
11.11.1 Hans Biomed Company Information
11.11.2 Hans Biomed Overview
11.11.3 Hans Biomed Soft Tissue Acellular Dermal Matrix (ADM) Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Hans Biomed Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hans Biomed Recent Developments
11.12 Xtant Medical
11.12.1 Xtant Medical Company Information
11.12.2 Xtant Medical Overview
11.12.3 Xtant Medical Soft Tissue Acellular Dermal Matrix (ADM) Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Xtant Medical Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Xtant Medical Recent Developments
11.13 Yantai Zhenghai Bio-Tech
11.13.1 Yantai Zhenghai Bio-Tech Company Information
11.13.2 Yantai Zhenghai Bio-Tech Overview
11.13.3 Yantai Zhenghai Bio-Tech Soft Tissue Acellular Dermal Matrix (ADM) Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Yantai Zhenghai Bio-Tech Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Yantai Zhenghai Bio-Tech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Soft Tissue Acellular Dermal Matrix (ADM) Industry Chain Analysis
12.2 Soft Tissue Acellular Dermal Matrix (ADM) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Soft Tissue Acellular Dermal Matrix (ADM) Production Mode & Process
12.4 Soft Tissue Acellular Dermal Matrix (ADM) Sales and Marketing
12.4.1 Soft Tissue Acellular Dermal Matrix (ADM) Sales Channels
12.4.2 Soft Tissue Acellular Dermal Matrix (ADM) Distributors
12.5 Soft Tissue Acellular Dermal Matrix (ADM) Customers
13 Soft Tissue Acellular Dermal Matrix (ADM) Market Dynamics
13.1 Soft Tissue Acellular Dermal Matrix (ADM) Industry Trends
13.2 Soft Tissue Acellular Dermal Matrix (ADM) Market Drivers
13.3 Soft Tissue Acellular Dermal Matrix (ADM) Market Challenges
13.4 Soft Tissue Acellular Dermal Matrix (ADM) Market Restraints
14 Key Findings in the Global Soft Tissue Acellular Dermal Matrix (ADM) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Soft Tissue Acellular Dermal Matrix (ADM) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Human Skin
Table 3. Major Manufacturers of Animal Skin
Table 4. Global Soft Tissue Acellular Dermal Matrix (ADM) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Region (2019-2024)
Table 9. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Region (2025-2030)
Table 10. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Pcs)
Table 11. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Region (2019-2024) & (K Pcs)
Table 12. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Region (2025-2030) & (K Pcs)
Table 13. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Region (2019-2024)
Table 14. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Region (2025-2030)
Table 15. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Manufacturers (2019-2024) & (K Pcs)
Table 16. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Share by Manufacturers (2019-2024)
Table 17. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Soft Tissue Acellular Dermal Matrix (ADM), Industry Ranking, 2021 VS 2022 VS 2023
Table 20. Soft Tissue Acellular Dermal Matrix (ADM) Price by Manufacturers (2019-2024) & (US$/Pc)
Table 21. Global Soft Tissue Acellular Dermal Matrix (ADM) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Soft Tissue Acellular Dermal Matrix (ADM) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Tissue Acellular Dermal Matrix (ADM) as of 2023)
Table 23. Global Key Manufacturers of Soft Tissue Acellular Dermal Matrix (ADM), Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Soft Tissue Acellular Dermal Matrix (ADM), Product Offered and Application
Table 25. Global Key Manufacturers of Soft Tissue Acellular Dermal Matrix (ADM), Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Type (2019-2024) & (K Pcs)
Table 28. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Type (2025-2030) & (K Pcs)
Table 29. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Share by Type (2019-2024)
Table 30. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Share by Type (2025-2030)
Table 31. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Share by Type (2019-2024)
Table 34. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Share by Type (2025-2030)
Table 35. Soft Tissue Acellular Dermal Matrix (ADM) Price by Type (2019-2024) & (US$/Pc)
Table 36. Global Soft Tissue Acellular Dermal Matrix (ADM) Price Forecast by Type (2025-2030) & (US$/Pc)
Table 37. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Application (2019-2024) & (K Pcs)
Table 38. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Application (2025-2030) & (K Pcs)
Table 39. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Share by Application (2019-2024)
Table 40. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Share by Application (2025-2030)
Table 41. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Share by Application (2019-2024)
Table 44. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Share by Application (2025-2030)
Table 45. Soft Tissue Acellular Dermal Matrix (ADM) Price by Application (2019-2024) & (US$/Pc)
Table 46. Global Soft Tissue Acellular Dermal Matrix (ADM) Price Forecast by Application (2025-2030) & (US$/Pc)
Table 47. US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Sales by Type (2019-2024) & (K Pcs)
Table 48. US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Sales by Type (2025-2030) & (K Pcs)
Table 49. US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Sales by Application (2019-2024) & (K Pcs)
Table 52. US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Sales by Application (2025-2030) & (K Pcs)
Table 53. US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Sales by Country (2019-2024) & (K Pcs)
Table 59. US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Sales by Country (2025-2030) & (K Pcs)
Table 60. Europe Soft Tissue Acellular Dermal Matrix (ADM) Sales by Type (2019-2024) & (K Pcs)
Table 61. Europe Soft Tissue Acellular Dermal Matrix (ADM) Sales by Type (2025-2030) & (K Pcs)
Table 62. Europe Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Soft Tissue Acellular Dermal Matrix (ADM) Sales by Application (2019-2024) & (K Pcs)
Table 65. Europe Soft Tissue Acellular Dermal Matrix (ADM) Sales by Application (2025-2030) & (K Pcs)
Table 66. Europe Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Soft Tissue Acellular Dermal Matrix (ADM) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Soft Tissue Acellular Dermal Matrix (ADM) Sales by Country (2019-2024) & (K Pcs)
Table 72. Europe Soft Tissue Acellular Dermal Matrix (ADM) Sales by Country (2025-2030) & (K Pcs)
Table 73. China Soft Tissue Acellular Dermal Matrix (ADM) Sales by Type (2019-2024) & (K Pcs)
Table 74. China Soft Tissue Acellular Dermal Matrix (ADM) Sales by Type (2025-2030) & (K Pcs)
Table 75. China Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Soft Tissue Acellular Dermal Matrix (ADM) Sales by Application (2019-2024) & (K Pcs)
Table 78. China Soft Tissue Acellular Dermal Matrix (ADM) Sales by Application (2025-2030) & (K Pcs)
Table 79. China Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Soft Tissue Acellular Dermal Matrix (ADM) Sales by Type (2019-2024) & (K Pcs)
Table 82. Asia Soft Tissue Acellular Dermal Matrix (ADM) Sales by Type (2025-2030) & (K Pcs)
Table 83. Asia Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Soft Tissue Acellular Dermal Matrix (ADM) Sales by Application (2019-2024) & (K Pcs)
Table 86. Asia Soft Tissue Acellular Dermal Matrix (ADM) Sales by Application (2025-2030) & (K Pcs)
Table 87. Asia Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Soft Tissue Acellular Dermal Matrix (ADM) Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Soft Tissue Acellular Dermal Matrix (ADM) Sales by Region (2019-2024) & (K Pcs)
Table 93. Asia Soft Tissue Acellular Dermal Matrix (ADM) Sales by Region (2025-2030) & (K Pcs)
Table 94. Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Sales by Type (2019-2024) & (K Pcs)
Table 95. Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Sales by Type (2025-2030) & (K Pcs)
Table 96. Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Sales by Application (2019-2024) & (K Pcs)
Table 99. Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Sales by Application (2025-2030) & (K Pcs)
Table 100. Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Sales by Country (2019-2024) & (K Pcs)
Table 106. Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Sales by Country (2025-2030) & (K Pcs)
Table 107. Zimmer Biomet Company Information
Table 108. Zimmer Biomet Description and Major Businesses
Table 109. Zimmer Biomet Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)
Table 110. Zimmer Biomet Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Zimmer Biomet Recent Developments
Table 112. Allergan Company Information
Table 113. Allergan Description and Major Businesses
Table 114. Allergan Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)
Table 115. Allergan Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Allergan Recent Developments
Table 117. Stryker Company Information
Table 118. Stryker Description and Major Businesses
Table 119. Stryker Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)
Table 120. Stryker Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Stryker Recent Developments
Table 122. MTF Biologics Company Information
Table 123. MTF Biologics Description and Major Businesses
Table 124. MTF Biologics Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)
Table 125. MTF Biologics Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. MTF Biologics Recent Developments
Table 127. LifeNet Health Company Information
Table 128. LifeNet Health Description and Major Businesses
Table 129. LifeNet Health Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)
Table 130. LifeNet Health Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. LifeNet Health Recent Developments
Table 132. Integra LifeSciences Company Information
Table 133. Integra LifeSciences Description and Major Businesses
Table 134. Integra LifeSciences Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)
Table 135. Integra LifeSciences Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Integra LifeSciences Recent Developments
Table 137. Medtronic Company Information
Table 138. Medtronic Description and Major Businesses
Table 139. Medtronic Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)
Table 140. Medtronic Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Medtronic Recent Developments
Table 142. Arthrex Company Information
Table 143. Arthrex Description and Major Businesses
Table 144. Arthrex Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)
Table 145. Arthrex Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Arthrex Recent Developments
Table 147. Straumann Company Information
Table 148. Straumann Description and Major Businesses
Table 149. Straumann Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)
Table 150. Straumann Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Straumann Recent Developments
Table 152. Wright Medical Group Company Information
Table 153. Wright Medical Group Description and Major Businesses
Table 154. Wright Medical Group Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)
Table 155. Wright Medical Group Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Wright Medical Group Recent Developments
Table 157. Hans Biomed Company Information
Table 158. Hans Biomed Description and Major Businesses
Table 159. Hans Biomed Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)
Table 160. Hans Biomed Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Hans Biomed Recent Developments
Table 162. Xtant Medical Company Information
Table 163. Xtant Medical Description and Major Businesses
Table 164. Xtant Medical Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)
Table 165. Xtant Medical Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Xtant Medical Recent Developments
Table 167. Yantai Zhenghai Bio-Tech Company Information
Table 168. Yantai Zhenghai Bio-Tech Description and Major Businesses
Table 169. Yantai Zhenghai Bio-Tech Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)
Table 170. Yantai Zhenghai Bio-Tech Soft Tissue Acellular Dermal Matrix (ADM) Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Yantai Zhenghai Bio-Tech Recent Developments
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Soft Tissue Acellular Dermal Matrix (ADM) Distributors List
Table 175. Soft Tissue Acellular Dermal Matrix (ADM) Customers List
Table 176. Soft Tissue Acellular Dermal Matrix (ADM) Market Trends
Table 177. Soft Tissue Acellular Dermal Matrix (ADM) Market Drivers
Table 178. Soft Tissue Acellular Dermal Matrix (ADM) Market Challenges
Table 179. Soft Tissue Acellular Dermal Matrix (ADM) Market Restraints
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Soft Tissue Acellular Dermal Matrix (ADM) Product Picture
Figure 2. Global Soft Tissue Acellular Dermal Matrix (ADM) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Soft Tissue Acellular Dermal Matrix (ADM) Market Share by Type: 2023 & 2030
Figure 4. Human Skin Product Picture
Figure 5. Animal Skin Product Picture
Figure 6. Global Soft Tissue Acellular Dermal Matrix (ADM) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Soft Tissue Acellular Dermal Matrix (ADM) Market Share by Application: 2023 & 2030
Figure 8. Plastic Surgery
Figure 9. Gynecology
Figure 10. Others
Figure 11. Soft Tissue Acellular Dermal Matrix (ADM) Report Years Considered
Figure 12. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue (2019-2030) & (US$ Million)
Figure 14. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 15. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 16. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Region (2019-2030)
Figure 17. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales (2019-2030) & (K Pcs)
Figure 18. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Pcs)
Figure 19. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Region (2019-2030)
Figure 20. US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Sales YoY (2019-2030) & (K Pcs)
Figure 21. US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Revenue YoY (2019-2030) & (US$ Million)
Figure 22. Europe Soft Tissue Acellular Dermal Matrix (ADM) Sales YoY (2019-2030) & (K Pcs)
Figure 23. Europe Soft Tissue Acellular Dermal Matrix (ADM) Revenue YoY (2019-2030) & (US$ Million)
Figure 24. China Soft Tissue Acellular Dermal Matrix (ADM) Sales YoY (2019-2030) & (K Pcs)
Figure 25. China Soft Tissue Acellular Dermal Matrix (ADM) Revenue YoY (2019-2030) & (US$ Million)
Figure 26. Asia (excluding China) Soft Tissue Acellular Dermal Matrix (ADM) Sales YoY (2019-2030) & (K Pcs)
Figure 27. Asia (excluding China) Soft Tissue Acellular Dermal Matrix (ADM) Revenue YoY (2019-2030) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Sales YoY (2019-2030) & (K Pcs)
Figure 29. Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Revenue YoY (2019-2030) & (US$ Million)
Figure 30. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Share by Manufacturers (2023)
Figure 31. The Soft Tissue Acellular Dermal Matrix (ADM) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 32. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Share by Manufacturers (2023)
Figure 33. The Top 5 and 10 Largest Manufacturers of Soft Tissue Acellular Dermal Matrix (ADM) in the World: Market Share by Soft Tissue Acellular Dermal Matrix (ADM) Revenue in 2023
Figure 34. Global Soft Tissue Acellular Dermal Matrix (ADM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 35. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Type (2019-2030)
Figure 36. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Type (2019-2030)
Figure 37. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Application (2019-2030)
Figure 38. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Application (2019-2030)
Figure 39. US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Type (2019-2030)
Figure 40. US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Type (2019-2030)
Figure 41. US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Application (2019-2030)
Figure 42. US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Application (2019-2030)
Figure 43. US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Revenue Share by Country (2019-2030)
Figure 44. US & Canada Soft Tissue Acellular Dermal Matrix (ADM) Sales Share by Country (2019-2030)
Figure 45. US Soft Tissue Acellular Dermal Matrix (ADM) Revenue (2019-2030) & (US$ Million)
Figure 46. Canada Soft Tissue Acellular Dermal Matrix (ADM) Revenue (2019-2030) & (US$ Million)
Figure 47. Europe Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Type (2019-2030)
Figure 48. Europe Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Type (2019-2030)
Figure 49. Europe Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Application (2019-2030)
Figure 50. Europe Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Application (2019-2030)
Figure 51. Europe Soft Tissue Acellular Dermal Matrix (ADM) Revenue Share by Country (2019-2030)
Figure 52. Europe Soft Tissue Acellular Dermal Matrix (ADM) Sales Share by Country (2019-2030)
Figure 53. Germany Soft Tissue Acellular Dermal Matrix (ADM) Revenue (2019-2030) & (US$ Million)
Figure 54. France Soft Tissue Acellular Dermal Matrix (ADM) Revenue (2019-2030) & (US$ Million)
Figure 55. U.K. Soft Tissue Acellular Dermal Matrix (ADM) Revenue (2019-2030) & (US$ Million)
Figure 56. Italy Soft Tissue Acellular Dermal Matrix (ADM) Revenue (2019-2030) & (US$ Million)
Figure 57. Russia Soft Tissue Acellular Dermal Matrix (ADM) Revenue (2019-2030) & (US$ Million)
Figure 58. China Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Type (2019-2030)
Figure 59. China Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Type (2019-2030)
Figure 60. China Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Application (2019-2030)
Figure 61. China Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Application (2019-2030)
Figure 62. Asia Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Type (2019-2030)
Figure 63. Asia Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Type (2019-2030)
Figure 64. Asia Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Application (2019-2030)
Figure 65. Asia Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Application (2019-2030)
Figure 66. Asia Soft Tissue Acellular Dermal Matrix (ADM) Revenue Share by Region (2019-2030)
Figure 67. Asia Soft Tissue Acellular Dermal Matrix (ADM) Sales Share by Region (2019-2030)
Figure 68. Japan Soft Tissue Acellular Dermal Matrix (ADM) Revenue (2019-2030) & (US$ Million)
Figure 69. South Korea Soft Tissue Acellular Dermal Matrix (ADM) Revenue (2019-2030) & (US$ Million)
Figure 70. China Taiwan Soft Tissue Acellular Dermal Matrix (ADM) Revenue (2019-2030) & (US$ Million)
Figure 71. Southeast Asia Soft Tissue Acellular Dermal Matrix (ADM) Revenue (2019-2030) & (US$ Million)
Figure 72. India Soft Tissue Acellular Dermal Matrix (ADM) Revenue (2019-2030) & (US$ Million)
Figure 73. Australia Soft Tissue Acellular Dermal Matrix (ADM) Revenue (2019-2030) & (US$ Million)
Figure 74. Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Type (2019-2030)
Figure 75. Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Type (2019-2030)
Figure 76. Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Application (2019-2030)
Figure 77. Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Application (2019-2030)
Figure 78. Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Revenue Share by Country (2019-2030)
Figure 79. Middle East, Africa and Latin America Soft Tissue Acellular Dermal Matrix (ADM) Sales Share by Country (2019-2030)
Figure 80. Brazil Soft Tissue Acellular Dermal Matrix (ADM) Revenue (2019-2030) & (US$ Million)
Figure 81. Mexico Soft Tissue Acellular Dermal Matrix (ADM) Revenue (2019-2030) & (US$ Million)
Figure 82. Turkey Soft Tissue Acellular Dermal Matrix (ADM) Revenue (2019-2030) & (US$ Million)
Figure 83. Israel Soft Tissue Acellular Dermal Matrix (ADM) Revenue (2019-2030) & (US$ Million)
Figure 84. GCC Countries Soft Tissue Acellular Dermal Matrix (ADM) Revenue (2019-2030) & (US$ Million)
Figure 85. Soft Tissue Acellular Dermal Matrix (ADM) Value Chain
Figure 86. Soft Tissue Acellular Dermal Matrix (ADM) Production Process
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Soft Tissue Acellular Dermal Matrix (ADM) in 2024?
The global market size of Soft Tissue Acellular Dermal Matrix (ADM) in 2024 was 89.2 Million USD.
What was the global market size of Soft Tissue Acellular Dermal Matrix (ADM) in 2030?
Which companies rank high in the global Soft Tissue Acellular Dermal Matrix (ADM) market?
What is the annual compound growth rate of the global Soft Tissue Acellular Dermal Matrix (ADM) market size from 2024 to 2030?
Which region is expected to have the highest market share?
Related Reports
Global Soft Tissue Acellular Dermal Matrix (ADM) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Soft Tissue Acellular Dermal Matrix (ADM) market is projected to grow from US$ 91.45 million in 2025 to US$ 111 million by 2032, at a CAGR of 2.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-25
Pages: 151
USD 4900.00
(Single User License)
Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Soft Tissue Acellular Dermal Matrix (ADM) market size was US$ 91.45 million in 2025 and is forecast to reach a readjusted size of US$ 111 million by 2032 with a CAGR of 2.8% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 94
USD 4250.00
(Single User License)
Global Soft Tissue Acellular Dermal Matrix (ADM) Market Research Report 2026
The global Soft Tissue Acellular Dermal Matrix (ADM) market was valued at US$ 91.45 million in 2025 and is anticipated to reach US$ 111 million by 2032, at a CAGR of 2.8% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 120
USD 2900.00
(Single User License)
Soft Tissue Acellular Dermal Matrix (ADM)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Soft Tissue Acellular Dermal Matrix (ADM) was estimated to be worth US$ 91.45 million in 2025 and is projected to reach US$ 111 million, growing at a CAGR of 2.8% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 123
USD 3950.00
(Single User License)
Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Soft Tissue Acellular Dermal Matrix (ADM) market size was US$ 89.2 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 91
USD 4250.00
(Single User License)
Global Soft Tissue Acellular Dermal Matrix (ADM) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Soft Tissue Acellular Dermal Matrix (ADM) market is projected to grow from US$ 89.2 million in 2024 to US$ 108 million by 2031, at a CAGR of 2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 153
USD 4900.00
(Single User License)
Soft Tissue Acellular Dermal Matrix (ADM) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Soft Tissue Acellular Dermal Matrix (ADM) was estimated to be worth US$ 89.2 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 123
USD 3950.00
(Single User License)
Global Soft Tissue Acellular Dermal Matrix (ADM) Market Research Report 2025
The global market for Soft Tissue Acellular Dermal Matrix (ADM) was valued at US$ 89.2 million in the year 2024 and is projected to reach a revised size of US$ 108 million by 2031, growing at a CAGR of 2.8% during the forecast period.
Published Date: 2025-03-10
Pages: 94
USD 2900.00
(Single User License)
Global and United States Soft Tissue Acellular Dermal Matrix (ADM) Market Report & Forecast 2024-2030
The global Soft Tissue Acellular Dermal Matrix (ADM) revenue was US$ 76.8 million in 2023 and is forecast to a readjusted size of US$ 105 million by 2030 with a CAGR of 2.8% during the review period (2024-2030).
Published Date: 2024-11-15
Pages: 125
USD 4350.00
(Single User License)
Soft Tissue Acellular Dermal Matrix (ADM)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Soft Tissue Acellular Dermal Matrix (ADM) was estimated to be worth US$ 76.8 million in 2023 and is forecast to a readjusted size of US$ 105 million by 2030 with a CAGR of 2.8% during the forecast period 2024-2030.
Published Date: 2024-11-15
Pages: 126
USD 3950.00
(Single User License)
Global Soft Tissue Acellular Dermal Matrix (ADM) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Soft Tissue Acellular Dermal Matrix (ADM) market is projected to grow from US$ 91.45 million in 2025 to US$ 111 million by 2032, at a CAGR of 2.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-25
Pages: 151
USD 4900.00 (Single User License)Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Soft Tissue Acellular Dermal Matrix (ADM) market size was US$ 91.45 million in 2025 and is forecast to reach a readjusted size of US$ 111 million by 2032 with a CAGR of 2.8% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 94
USD 4250.00 (Single User License)Global Soft Tissue Acellular Dermal Matrix (ADM) Market Research Report 2026
The global Soft Tissue Acellular Dermal Matrix (ADM) market was valued at US$ 91.45 million in 2025 and is anticipated to reach US$ 111 million by 2032, at a CAGR of 2.8% from 2026 to 2032.
Published: 2026-01-08
Pages: 120
USD 2900.00 (Single User License)Soft Tissue Acellular Dermal Matrix (ADM)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Soft Tissue Acellular Dermal Matrix (ADM) was estimated to be worth US$ 91.45 million in 2025 and is projected to reach US$ 111 million, growing at a CAGR of 2.8% from 2026 to 2032.
Published: 2026-01-08
Pages: 123
USD 3950.00 (Single User License)Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Soft Tissue Acellular Dermal Matrix (ADM) market size was US$ 89.2 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 91
USD 4250.00 (Single User License)Global Soft Tissue Acellular Dermal Matrix (ADM) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Soft Tissue Acellular Dermal Matrix (ADM) market is projected to grow from US$ 89.2 million in 2024 to US$ 108 million by 2031, at a CAGR of 2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 153
USD 4900.00 (Single User License)Soft Tissue Acellular Dermal Matrix (ADM) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Soft Tissue Acellular Dermal Matrix (ADM) was estimated to be worth US$ 89.2 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 123
USD 3950.00 (Single User License)Global Soft Tissue Acellular Dermal Matrix (ADM) Market Research Report 2025
The global market for Soft Tissue Acellular Dermal Matrix (ADM) was valued at US$ 89.2 million in the year 2024 and is projected to reach a revised size of US$ 108 million by 2031, growing at a CAGR of 2.8% during the forecast period.
Published: 2025-03-10
Pages: 94
USD 2900.00 (Single User License)Global and United States Soft Tissue Acellular Dermal Matrix (ADM) Market Report & Forecast 2024-2030
The global Soft Tissue Acellular Dermal Matrix (ADM) revenue was US$ 76.8 million in 2023 and is forecast to a readjusted size of US$ 105 million by 2030 with a CAGR of 2.8% during the review period (2024-2030).
Published: 2024-11-15
Pages: 125
USD 4350.00 (Single User License)Soft Tissue Acellular Dermal Matrix (ADM)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Soft Tissue Acellular Dermal Matrix (ADM) was estimated to be worth US$ 76.8 million in 2023 and is forecast to a readjusted size of US$ 105 million by 2030 with a CAGR of 2.8% during the forecast period 2024-2030.
Published: 2024-11-15
Pages: 126
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now